Autosomal recessive SLC30A9 Mutations in a Proband with a Cerebro-Renal Syndrome and No Parental Consanguinity

An SLC30A9 associated cerebro renal syndrome was first reported in consanguineous Bedouin kindred by Perez et al in 2017. While the function of the gene has not yet been fully elucidated, it may be implicated in Wnt signaling, nuclear regulation, as well as cell and mitochondrial zinc regulation. In this research report, we present a female proband with two distinct, inherited autosomal recessive loss of function SLC30A9 variants from unrelated parents. To our knowledge, this is the first reported case of a possible SLC30A9 associated cerebro renal syndrome in a nonconsanguineous family. Furthermore, a limited statistical analysis was conducted to identify possible allele frequency differences between populations. Our findings provide further support for an SLC30A9 associated cerebro renal syndrome and may help further clarify the function of this gene.

In this case study, we describe a female proband with two distinct, inherited loss of function mutations in SLC30A9 presenting with clinical findings similar to those described by Perez et al. To our knowledge, this is the first known case of a possible SLC30A9-associated cerebro-renal syndrome in a non-consanguineous family. The variants were identified through next-generation whole exome sequencing (WES) and were validated using the Sanger sequencing method. This case study may provide further support for an SLC30A9-associated cerebro-renal syndrome and may offer more insight in the role of SLC30A9 in metabolism and human disease.

Clinical Presentation:
The proband first presented to our clinic and agency for services evaluation from the

WES Analysis:
Samples from the proband (around age range 5-10 years old) and two relatives were sent to Novogene (Sacramento, CA) for clinical WES. Variant calling and interpretation was performed using the Cogenica platform (Congenica Limited, Cambridge, UK). Coverage and mapping statistics for whole exome sequencing performed on the family are shown in . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 22, 2021. Sanger sequencing chromatograms are presented in Figure 1. Methods are discussed at length in Supplemental Information.

Population Analysis of SLC30A9 Variants
Given that this proband was of African American descent, it was hypothesized that variants in SLC30A9 may be more common in individuals with African ancestry. Pathogenic

Discussion:
In this report, we present a female proband who is compound heterozygous for two novel loss of function variants in SLC30A9. There are several similarities between her phenotype and the clinical features reported in a Bedouin family by Perez et al. We believe that our findings provide additional support for the existence of a SLC30A9-associated cerebro-renal syndrome, which in turn emphasizes the gene's importance in zinc homeostasis.
Individuals with African Ancestry do appear to be more likely to carry missense and LoF mutations in SLC30A9 variants when compared to individuals with Ashkenazi Jewish and "Other" gnomAD populations, although individuals with European ancestry appear to be most at risk.
Both experimental and observational studies have demonstrated the role of zinc metabolism in neurological diseases such as neurodegenerative disorders, autism spectrum disorder, movement disorders, amyotrophic lateral sclerosis, mood disorders, traumatic brain injury, strokes, and seizures (Prakash, Bharti, and Majeed 2015). Zinc released from neuron synapses plays a role in regulating GABA, glycine, N-methyl-D-aspartate (NMDA), and α-. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Although the role of zinc transporters and homeostasis in renal pathophysiology is less characterized, several observational studies support the clinical relevance of zinc in renal disease.
Individuals with CKD were found to have decreased concentrations of plasma and urinary zinc, as well as an increased fractional excretion of zinc when compared to healthy control subjects (Damianaki et al. 2020). Low serum zinc levels may also be associated with the progression of diabetic nephropathy, given that it was found to be inversely correlated with microalbuminuria and serum creatinine, and directly correlated with eGFR in diabetic individuals (Al-Timimi,

Sulieman, and Hussen 2014). Analysis of data from the Korean Genome and Epidemiology
Study suggests a possible causative relationship; individuals whose dietary zinc consumption was calculated to be in the first quartile had a 36% greater risk of developing CKD than those whose zinc intake was in the fourth quartile (Joo et al. 2021).
Experimental studies have mixed results in support for these findings. Zinc supplementation has been found to have a protective effect against gentamicin-induced nephropathy in rats (Teslariu et al. 2016). However, in children with CKD, zinc supplementation was found to have a significant positive change in body mass and resulted in "normalization," but no significant change in serum albumin, zinc and CRP levels (Escobedo-Monge et al. 2019).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 22, 2021. ;https://doi.org/10.1101https://doi.org/10. /2021 There are several limitations to our conclusions. Although we have made every effort to provide tangible clinical benefit to the proband and her family, clinic visits were sporadic, and the patient was eventually lost to follow-up. Consequently, it is likely that additional clinical features were not presented in this case report, as we were unable to obtain all medical records regarding the proband's care.
Challenges with obtaining paternal DNA samples provide further uncertainty regarding the significance of a 9p24.1-p24.1 interstitial duplication (which contains KDM4C) found in the proband. While the variant was not present in the mother, paternal inheritance cannot be ruled in or out; however, the proband's clinical presentation aligns more with the phenotype seen in the Bedouin family, rather than KDM4C-associated disorders such as schizophrenia and autism (Kato et al. 2020). Furthermore, it is also generally accepted that genome duplications tend to be better tolerated than deletions (Brewer et al. 1999).
Our population analysis of SLC30A9 variants in gnomAD also has several limitations.
While the gnomAD database attempts to exclude individuals with severe pediatric disease and their first-degree relatives, it is still possible for some individuals with severe disease to be included in the dataset. Furthermore, given that the allele counts are small, the power of the analysis was limited. It is also important to note that individuals with African ancestry are underrepresented in genomics research and may therefore erroneously appear to have a smaller risk of genetic disease (Bentley, Callier, and Rotimi 2020).

Data Availability Statement
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 22, 2021. ;https://doi.org/10.1101https://doi.org/10. /2021 The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 22, 2021. ;  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 22, 2021. ;https://doi.org/10.1101https://doi.org/10. /2021